EP3356336A1 - Verfahren zur herstellung von n-(1,3,4-oxadiazol-2-yl)arylcarboxamiden - Google Patents

Verfahren zur herstellung von n-(1,3,4-oxadiazol-2-yl)arylcarboxamiden

Info

Publication number
EP3356336A1
EP3356336A1 EP16777581.6A EP16777581A EP3356336A1 EP 3356336 A1 EP3356336 A1 EP 3356336A1 EP 16777581 A EP16777581 A EP 16777581A EP 3356336 A1 EP3356336 A1 EP 3356336A1
Authority
EP
European Patent Office
Prior art keywords
methyl
formula
alkyl
iii
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16777581.6A
Other languages
German (de)
English (en)
French (fr)
Inventor
Christian Funke
Arnd Neeff
Sergii Pazenok
Norbert Lui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer CropScience AG
Original Assignee
Bayer CropScience AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer CropScience AG filed Critical Bayer CropScience AG
Publication of EP3356336A1 publication Critical patent/EP3356336A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/1131,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/82Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with three ring hetero atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Definitions

  • the invention relates to a process for the preparation of herbicidally active N- (1, 3,4-oxadiazol-2-yl) arylcarboxamiden.
  • WO 2012/126932 A1 discloses herbicidally active N- (1, 3,4-oxadiazol-2-yl) arylcarboxamides. There is also described a process for their preparation. In this process, substituted benzoic acids are substituted with 2-amino-1, 3,4-oxadiazoles which are substituted in the 5-position in the presence of activating
  • Reagents such as carbonyl imidazole (CDI), dicyclohexylcarbodiimide or 2,4,6-
  • such reagents are unsuitable for large scale reactions because they are very expensive and are not recyclable.
  • 2216 is known that substituted benzoic acid chlorides react with 2-amino-1, 3,4-oxadiazole not only to the desired 2-Benzoylamino1, 3,4-oxadiazoles but also to the isomers.
  • 3 Benzoyl-2-imino-1,3,4-oxadiazolines are known that substituted benzoic acid chlorides react with 2-amino-1, 3,4-oxadiazole not only to the desired 2-Benzoylamino1, 3,4-oxadiazoles but also to the isomers.
  • the object of the present invention is to provide a method for
  • An object of the present invention is thus a process for the preparation of N- (1, 3,4-oxadiazol-2-yl) aryl-carboxamides of the general formula (I) by reaction of 2-amino-1, 3,4-oxadiazoles of the general formula (II) with benzoic acids of the general formula (III),
  • R 1 is hydrogen, C 3 -C 2 cycloalkyl, Ci-C 8 -alkyl, C 5 alkoxy,
  • R 2 is hydrogen, C 1 -C 8 -alkyl or halogen
  • R 3 is hydrogen, C 1 -C 8 -alkyl, C 1 -C 8 -alkyl sulfenyl, C 1 -C 8 -alkylsulfinyl or C 1 -C 8 -alkylsulfonyl,
  • R 4 is C 1 -C 5 -alkyl or C 1 -C 3 -haloalkyl
  • R 5 is Ci-Ci 2 alkyl or phenyl.
  • Alkyl radicals mean e.g. Methyl, ethyl, n- or i-propyl, n-, i-, t- or 2-butyl, pentyls, hexyls, such as n-hexyl, i-hexyl and 1, 3-dimethylbutyl.
  • alkoxy and cycloalkyl radicals mean e.g. Methyl, ethyl, n- or i-propyl, n-, i-, t- or 2-butyl, pentyls, hexyls, such as n-hexyl, i-hexyl and 1, 3-dimethylbutyl.
  • alkoxy and cycloalkyl radicals mean e.g. Methyl, ethyl, n- or i-propyl, n-, i-, t- or 2-butyl, pentyls,
  • Halogen is fluorine, chlorine is bromine or iodine, preferably fluorine or chlorine.
  • the activator and the compounds of the formula (III) are usually employed in a molar ratio of from 0.5 to 3, preferably from 1 to 2, particularly preferably from 1.2 to 1.9.
  • the activator used is preferably thionyl chloride, phosgene or diphosgene, particularly preferably thionyl chloride.
  • the base of the formula (IV) and the compounds of the formula (III) are usually employed in a molar ratio of from 0.5 to 10, preferably from 1 to 3, particularly preferably from 1 to 2.5.
  • the process according to the invention is generally carried out in a solvent.
  • Suitable solvents are inert organic solvents, preferably aliphatic, alicyclic or aromatic hydrocarbons, such as petroleum ether, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene and decalin; halogenated hydrocarbons, such as chlorobenzene, dichlorobenzene, dichloromethane, chloroform, tetrachloromethane, dichloroethane and trichloroethane; Esters such as ethyl acetate and isopropyl acetate; Ethers such as diethyl ether, diisopropyl ether, methyl
  • the inventive method in a temperature range of -5 ° to 50 ° C, preferably 0 ° to 25 ° C is performed.
  • the process according to the invention is usually carried out in such a way that the compounds of the formulas (II), (III) and (IV) are initially charged in a solvent and the activator is slowly added dropwise with stirring or introduced in the case of phosgene.
  • the progress of the reaction can be monitored by HPLC control. Full implementation is usually done after 10 to 20 hours. After complete reaction, the reaction mixture is cooled and the product usually precipitates almost quantitatively. Alternatively, the
  • reaction mixture with a polar solvent such as water or alcohols such as isopropanol diluted.
  • the reaction product of formula (I) is highly pure and can be further purified if necessary. Especially advantageous is to allow the reaction mixture at a temperature between 20 and 35 ° C within 3 to 6 hours with water.
  • the product is obtained in a quickly filterable form.
  • the base of the formula (IV) can be recovered by distillation to about 95%.
  • R 1 is hydrogen, methyl, ethyl, n-propyl, i-propyl or phenyl,
  • R 2 is methyl or chlorine
  • R 3 is methylsulfenyl, methylsulfinyl or methylsulfonyl
  • R 4 is trifluoromethyl
  • R 5 is methyl or n-butyl.
  • R 1 is methyl
  • R 2 is methyl or chlorine
  • R 3 is methylsulfonyl
  • R 4 is trifluoromethyl
  • R 5 is methyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Laminated Bodies (AREA)
  • Shaping By String And By Release Of Stress In Plastics And The Like (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
EP16777581.6A 2015-09-28 2016-09-23 Verfahren zur herstellung von n-(1,3,4-oxadiazol-2-yl)arylcarboxamiden Withdrawn EP3356336A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15187023 2015-09-28
PCT/EP2016/072629 WO2017055175A1 (de) 2015-09-28 2016-09-23 Verfahren zur herstellung von n-(1,3,4-oxadiazol-2-yl)arylcarboxamiden

Publications (1)

Publication Number Publication Date
EP3356336A1 true EP3356336A1 (de) 2018-08-08

Family

ID=54207378

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16777581.6A Withdrawn EP3356336A1 (de) 2015-09-28 2016-09-23 Verfahren zur herstellung von n-(1,3,4-oxadiazol-2-yl)arylcarboxamiden

Country Status (10)

Country Link
US (1) US10189800B2 (enExample)
EP (1) EP3356336A1 (enExample)
JP (1) JP2018529703A (enExample)
KR (1) KR20180059456A (enExample)
CN (1) CN108137519A (enExample)
BR (1) BR112018006202A2 (enExample)
IL (1) IL258320B (enExample)
MX (1) MX2018003963A (enExample)
TW (1) TW201711566A (enExample)
WO (1) WO2017055175A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018202535A1 (de) * 2017-05-04 2018-11-08 Bayer Cropscience Aktiengesellschaft Herbizid wirksame 4-difluormethylbenzoylamide
KR102868734B1 (ko) * 2020-12-17 2025-10-02 주식회사 팜한농 N-(1-메틸-1h-테트라졸-5-일)-2-(((2-메틸-2h-테트라졸-5-일)메톡시)메틸)-6-(트리플루오로메틸)니코틴아마이드의 제조 방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077690A1 (en) * 2000-09-29 2004-04-22 Bing-Yan Zhu Quaternary amidino based inhibitors of factor xa
US20080090834A1 (en) * 2006-07-06 2008-04-17 Pfizer Inc Selective azole pde10a inhibitor compounds
JP2009091267A (ja) * 2007-10-04 2009-04-30 Kyorin Pharmaceut Co Ltd アミド誘導体及びそれらを有効成分とするスフィンゴシン−1−リン酸−1(s1p1)受容体選択的アゴニスト
EP3556367A1 (en) * 2009-07-06 2019-10-23 Aerpio Therapeutics, Inc. Benzosulfonamide derivatives, compositions thereof, and their use in the treatment of cancer or metastasis
JP5805767B2 (ja) * 2010-09-01 2015-11-10 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH N−(テトラゾール−5−イル)アリールカルボキサミド類及びn−(トリアゾール−5−イル)アリールカルボキサミド類並びに除草剤としてのそれらの使用
BR112013023911B1 (pt) * 2011-03-22 2018-07-10 Bayer Intellectual Property Gmbh Amidas de ácido n-(1,3,4-oxadiazol-2-il)- arilcarboxílico, seu uso, composições herbicidas, e processo para combate de plantas indesejadas
CN103443107B (zh) * 2011-03-28 2016-04-20 弗·哈夫曼-拉罗切有限公司 噻唑并嘧啶化合物
JP6001048B2 (ja) * 2011-03-28 2016-10-05 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft チアゾロピリミジン化合物
AU2012331283A1 (en) * 2011-11-03 2014-05-22 Bayer Intellectual Property Gmbh Herbicidally active oxime-ether-substituted benzoylamides
CN102491971B (zh) * 2011-12-19 2017-03-01 北京理工大学 手性[(4-甲基-2-丙基-1h-苯并咪唑-6-酰胺)-1-基]甲基联苯类化合物及其制备方法和用途
EP2817296B1 (de) 2012-02-21 2016-08-31 Bayer Intellectual Property GmbH Herbizid wirksame 3-(sulfin-/sulfonimidoyl)-benzamide
US9682967B2 (en) 2013-01-28 2017-06-20 H. Lundbeck A/S N-substituted-5-substituted phthalamic acids as sortilin inhibitors
JP6398124B2 (ja) * 2014-03-10 2018-10-03 Meiji Seikaファルマ株式会社 2−アシルイミノピリジン誘導体の製造法

Also Published As

Publication number Publication date
TW201711566A (zh) 2017-04-01
US20180273496A1 (en) 2018-09-27
BR112018006202A2 (pt) 2018-10-09
US10189800B2 (en) 2019-01-29
KR20180059456A (ko) 2018-06-04
IL258320B (en) 2019-09-26
CN108137519A (zh) 2018-06-08
WO2017055175A1 (de) 2017-04-06
IL258320A (en) 2018-05-31
MX2018003963A (es) 2018-06-08
JP2018529703A (ja) 2018-10-11

Similar Documents

Publication Publication Date Title
EP2285779B1 (de) Verfahren zur Herstellung von Arylcarboxamiden
EP2501682B1 (de) Verfahren zum herstellen von 5-fluor-1-alkyl-3-fluoralkyl-1h-pyrazol-4-carbonsäurechloriden
JP6050358B2 (ja) ベンゾオキサジノンをアミンと反応させることによるテトラゾール置換アントラニル酸ジアミド誘導体の製造方法
WO2013007604A1 (de) Verfahren zur herstellung von tetrazol-substituierten anthranilsäurediamid-derivaten durch umsetzung von pyrazolsäuren mit anthranilsäureestern
JP6523334B2 (ja) 置換サイクロセリンの調製のための方法
JP2018027955A (ja) カルボキサミド類を製造する方法
EP2388260A1 (de) Herstellungsverfahren für einen Inhibitor eines Blutgerinnungsfaktors
EP3356336A1 (de) Verfahren zur herstellung von n-(1,3,4-oxadiazol-2-yl)arylcarboxamiden
DE1966974A1 (de) Dimethylformiminiumhalogensulfit- n-halogenide, verfahren zu deren herstellung sowie deren verwendung
EP2456747B1 (de) Verfahren zur Herstellung von Alkoxyenonen und Enaminoketonen
EP4367106A1 (de) Chirale 3-sulfinylbenzoesäuren
JP5140776B1 (ja) 1−置換−3−フルオロアルキルピラゾール−4−カルボン酸エステルの製造方法
EP3497084B1 (en) Process for the preparation of 3-amino-1-(2,6-disubstituted-phenyl)pyrazoles
EP2160391B1 (de) Nicotinamid-derivate als synthesebausteine zur herstellung von agrochemischen wirkstoffen und verfahren zu deren herstellung
WO2008155004A1 (de) Verfahren zur herstellung von dioxazin-derivaten
DE4032925A1 (de) Verfahren zur herstellung von 3-arylpyrrolderivaten

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180430

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20190802

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20191213